Raplon Bronchospasm AEs Within Labeled Incidence; Drug Withdrawn
Executive Summary
The postmarketing incidence of serious adverse events of bronchospasm with the anesthetic Raplon falls within the rate found in labeling, Organon states in a "Dear Healthcare Professional" letter recalling the product.